/PRNewswire/ The Prostate Cancer Foundation (PCF) today announced the Class of 2021 Young Investigator Award recipients totaling nearly $6.5 million in.
Share this article
Share this article
LOS ANGELES, May 25, 2021 /PRNewswire/ In recognition of Military Appreciation Month, the Prostate Cancer Foundation (PCF) announced today its new $2.5 million commitment to launch the Drew Foundation Precision Oncology Center of Excellence in collaboration with the University of California, San Francisco (UCSF) and the San Francisco VA Health Care System (SFVAHCS) to deliver best-in-class precision oncology treatments to Veterans with prostate cancer. PCF is committed to continuing to expand our partnership with the VA to advance cutting-edge research and care for Veterans with prostate cancer, said Jonathan W. Simons, MD, PCF president and CEO. Partnering with the University of California, San Francisco brings top expertise to our precision oncology efforts serving our nation s Veterans. UCSF researchers co-developed the latest FDA-approved PSMA-PET scan which zeroes in on prostate cancer that has spread through the body so it can be b
Local scientists research new method to “sniff out” prostate cancer with the help of dogs
Feb. 25, 2021 at 6:00 am
With the help of man’s best friend, scientists at the Prostate Cancer Foundation in Santa Monica have proven that a dog’s nose can be an accurate early detector for prostate cancer.
The implications of their recently released study are enormous as prostate cancer is one of the biggest killers for men in the US.
The team of researchers from the PCF, the Massachusetts Institute of Technology, Johns Hopkins University, and Medical Detection Dogs in the UK seek to use findings from this study to eventually develop a “robotic dog nose” potentially taking the form of a smartphone app that detects prostate cancer from urine samples.
Study Training Dogs To Detect Prostate Cancer Gets One Paw Closer To A Robotic Nose To Diagnose The Disease, Including Most Lethal Form
A study by Medical Detection Dogs, the Prostate Cancer Foundation, Massachusetts Institute of Technology, and Johns Hopkins University combined three current methods of diagnosing the disease for the first time to detect prostate cancer early
Larger-scale studies planned to develop a machine olfaction diagnostic tool - a robotic nose - that may ultimately be a smartphone app of the future; MIT developing prototype
News provided by
Share this article
Share this article
MILTON KEYNES, England and LOS ANGELES, Feb. 17, 2021 /PRNewswire/ New research from a multi-national, cross-disciplinary team of scientists from Medical Detection Dogs (MDD) in the UK, the Prostate Cancer Foundation (PCF), Massachusetts Institute of Technology (MIT), Johns Hopkins University – and a friendly pair of specially trained cancer-sniffing dogs at MDD – has